Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole plus methylphenidate versus placebo plus methylphenidate in children with attention deficit hyperactivity disorder
IRCT201612253979N6Phase 3Completed
- Sponsor
- Vice Chancellor for Research of Ahvaz University of Medical Sciences
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Pramipexole + methylphenidate with Placebo + methylphenidate (2 arms). Started Feb 2017; status: completed.
02
Drugs
pramipexolemethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT201612253979N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201612253979N6.